Skip to main content

Table 2 Peri-operative patient characteristics

From: Retroperitoneal lymph node dissection (RPLND) for malignant phenotype Leydig cell tumours of the testis: a 10-year experience

Case

Age [Side]

Path. features from Table1(Total)

Tumour markers

Pre-op. stage

Blood loss (ml)

Op. time (hours)

Complications

LOS (days)

Pathology at RPLND

Recurrence

DFS (months)

1

(63) Right

I, II, III, VI, VIII (5)

aFP 2bHCG<2 LDH 183

IIA (Ipsilateral Paraortic nodal uptake)

1500

6

Nil

11

LCT (180x65x25mm) Involvement of right ureter-> nephrectomy

Yes

N/A (died at 13 months)

2

(55) Left

II, III, V (3)

aFP 3bHCG<2 LDH 210

I

500

6

Nil

8

Benign

No

7 months

3

(72) Left

I, II, V, VI (4)

aFP 4bHCG<3 LDH 214

IIB (Ipsilateral Paraortic nodes, up to 5cm)

1500

6.5

AKI, Dialysed

8

LCT (120x85x40mm)

Yes-16 months (required further resection)

16 months (died at 36 months)

4

(67) Right

I, III (2)

aFP 6bHCG<3 LDH 186

I

1500

5.5

No

6

Benign

No

23 months

5

(61) Right

II (1)

aFP 3bHCG<3LDH 222

I

800

4.5

Pneumonia

9

Benign

No

16 months

  1. Path = histopathological; α-FP = α-fetoprotein protein; β-hCG = β-human chorionic gonadotrophin; LDH = lactate dehydrogenase; op = operative; LOS = length of stay; LCT = leydig cell tumour; DFS = disease-free survival.